Medicas AI is building the world’s first patient-centric agentic AI model for transforming drug discovery processes. The company are founded by world renowned LLM experts and pharmaceutical veterans who are passionate about shifting AI paradigm and making personalized medicine & healthcare solutions accessible to everyone


Our story
Medicas AI was born from a deeply personal experience — one that revealed both the fragility and potential of modern medicine.
Our founder, while undergoing treatment and taking tamoxifen, began to experience severe side effects. What was meant to be a life-saving medication also brought potential long-term risks - severe joint pains, increased fat liver risks…
The frustration of lacking effective medicine as well as lacking a personalized healthcare solution motivated our founder to build a 360 degree full solution and help close the gaps - the gaps that impact the entire pharmaceutical industry - physician - patient ecosystem.
The personal story led to the birth of Medicas. AI, where two female founders united with one mission - Shift AI paradigm and make personalized medicine & healthcare solutions accessible to everyone!
The Future We’re Building
​
At Medicas AI, we believe the next frontier of healthcare lies in human-AI collaboration — We are building an AI engine that thinks like a scientist: an intelligent system that doesn’t hallucinate, but accelerates drug discovery through long-horizon reasoning, self-validating hypotheses, and continuous self-learning.
​
Our founder’s journey began with pain and uncertainty. Today, it fuels a mission — to accelerate the development of personalized medicines and healthcare solutions like never before.

Our Mission
Shift AI Paradigm
Make personalized medicine & healthcare solutions accessible to everyone!